DuPont Home

Unit Dose Vials

Application Description

Manufacturers of Respiratory Drugs Rely on DuPont™ 20 Series Resins for Unit Dose Vials

DuPont™ 20 Series low density polyethylene (LDPE) resins are proven products for use in blow form-fill- seal medical packaging of drugs used for the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD). Typically, these drugs are packaged in unit dose vials.  Several pharmaceutical companies are currently using DuPont™ 20 Series resins for packaging their brand of these respiratory drugs.
Benefits Gained
  • Extremely low volatiles and extractables.
  • Superior resistance to environmental stress cracking.
Materials Selected and Why
DuPont™ 20 Series LDPE resins offer outstanding purity and consistency.  They are listed in FDA Drug Master File 1528 and are compliant with industry standards and global regulations.  What’s more, DuPont has provided a reliable supply to the medical packaging industry for more than 30 years and offers excellent analytical and technical support to help companies meet stringent industry requirements.

Because DuPont cannot anticipate or control the many different conditions under which this information and/or product may be used, it does not guarantee the applicability or the accuracy of this information or the suitability of its products in any given situation. Users of DuPont products should make their own tests to determine the suitability of each such product for their particular purposes. The data listed herein falls within the normal range of product properties but they should not be used to establish specification limits or used alone as the basis of design. Disclosure of this information is not a license to operate or a recommendation to infringe a patent of DuPont or others.